Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.

Rickels K, Rynn M, Iyengar M, Duff D.

J Clin Psychiatry. 2006 Jan;67(1):41-7.

PMID:
16426087
2.

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder.

Stocchi F, Nordera G, Jokinen RH, Lepola UM, Hewett K, Bryson H, Iyengar MK; Paroxetine Generalized Anxiety Disorder Study Team.

J Clin Psychiatry. 2003 Mar;64(3):250-8.

PMID:
12716265
3.

Remission rates in patients with anxiety disorders treated with paroxetine.

Ballenger JC.

J Clin Psychiatry. 2004 Dec;65(12):1696-707.

PMID:
15641876
4.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
5.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
6.

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder.

Davidson JR, Bose A, Wang Q.

J Clin Psychiatry. 2005 Nov;66(11):1441-6.

PMID:
16420082
7.
8.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
10.

A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder.

Bielski RJ, Bose A, Chang CC.

Ann Clin Psychiatry. 2005 Apr-Jun;17(2):65-9.

PMID:
16075658
11.

Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.

Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.

J Clin Psychiatry. 2002 Jul;63(7):577-84.

PMID:
12143913
12.

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder.

Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B.

Psychopharmacology (Berl). 2001 Nov;158(3):267-72.

PMID:
11713616
13.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
14.

Paroxetine treatment of generalized anxiety disorder.

Sheehan DV, Mao CG.

Psychopharmacol Bull. 2003 Spring;37 Suppl 1:64-75. Review.

PMID:
14566202
15.
16.

The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.

Misri S, Reebye P, Corral M, Milis L.

J Clin Psychiatry. 2004 Sep;65(9):1236-41.

PMID:
15367052
17.

Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.

Lydiard RB, Pitrosky B, Hackett D, White C.

J Clin Psychiatry. 2004 Jun;65(6):838-44.

PMID:
15291662
18.
19.

[Treatment of generalized anxiety: new pharmacologic approaches].

Boulenger JP.

Encephale. 1995 Nov-Dec;21(6):459-66. Review. French.

PMID:
8674471
20.

Supplemental Content

Support Center